ASLAN Pharmaceuticals Ltd (ASLN)
0.4471
-0.01
(-2.78%)
USD |
NASDAQ |
May 03, 16:00
0.4539
+0.01
(+1.52%)
After-Hours: 20:00
ASLAN Pharmaceuticals Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2018 | -39.47M |
| September 30, 2018 | -40.06M |
| June 30, 2018 | -38.36M |
| March 31, 2018 | -38.10M |
| December 31, 2017 | -34.12M |
| Date | Value |
|---|---|
| September 30, 2017 | -29.15M |
| June 30, 2017 | -13.99M |
| March 31, 2017 | -7.832M |
| December 31, 2016 | -5.789M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Dr Reddy's Laboratories Ltd | 664.30M |
| Concord Medical Services Holdings Ltd | -- |
| WAVE Life Sciences Ltd | -19.43M |
| Zai Lab Ltd | -198.18M |
| CytoMed Therapeutics Ltd | -2.555M |